adplus-dvertising
Connect with us

Business

LILLEY: Trudeau government plagued by vaccine troubles – Toronto Sun

Published

 on


Mistakes early in this process coming home to roost

Article content

The one job in Canadian politics I wouldn’t want to have right now is Anita Anand’s position in trying to secure vaccines.

There is the global demand that far outstrips supply, there is vaccine nationalism and the threat of export controls, we have production delays and the fact that mistakes by the Trudeau government early in this process are coming home to roost.

Add to all of that the daily media questions, the demands of premiers, mayors and average citizens all wanting to know when vaccine doses are arriving.

It’s a moving target and the answer to any of these questions can change in the blink of an eye. We were supposed to be getting 846,000 Moderna doses this week but that was delayed. The shipment was split with 255,600 doses arriving on March 24 and the remaining 590,400 on March 30.

That is already a week behind schedule for a system that is running pretty much on a just in time delivery model. Now that second shipment is scheduled for April 1 and sources I have spoken to in various governments say there is word the doses expected April 5 could be delayed.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Anand said Friday that Canada’s strategy of “managing the bumps in the road” includes our diversified vaccine portfolio and taking supplies from a variety of manufacturers and locations.

  1. A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020.

    Tam’s office admits rocket ship modelling takes ‘simplified approach’ to projections

  2. Premier Doug Ford didn't mince words during a briefing on Friday, March 26, 2021, when he harangued Prime Minister Justin Trudeau for an inconsistent delivery of vaccines to Ontario that is making it difficult for provincial health officials to get shots in arms.

    Ford says vaccine supply ‘becoming a joke’

It works to a degree, but with India currently halting shipments and the EU threatening to, Canada is in a tough spot.

“We’ve been assured that the doses have been cleared to leave Europe for next week and the week after,” Anand said.

Yet the way that EU export controls work, they could pull their authorization to allow the shipments at any time. One of the key metrics the EU says it will use to determine if exports can continue is how the epidemiological status of the receiving country compares to member states.

Right now, Canada is in a better position in terms of COVID infections per million people than every country in the EU other than Portugal. We should expect vaccine delays from Europe for both Pfizer and Moderna doses.

That leaves AstraZeneca as the other approved vaccine that is actually manufacturing. Johnson & Johnson can’t give a supply date.

We apologize, but this video has failed to load.

When it comes to AstraZeneca, Canada is really dependent on the generosity of other countries. We secured a shipment of 500,000 doses from the Serum Institute of India, but the remaining 2.9 million doses we are supposed to be getting from there are now up in the air. India has stopped major exports and we don’t know how long that will last.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

The United States has offered up 1.5 million doses that they don’t need and are set to expire before they could use them but that is not a steady supply. Not a single shipment of the 20 million AstraZeneca doses Canada has contracted the company for have shipped — we’ve only received bonus doses.

Right now, by my count, Canada sits at about 52nd in the world in vaccinating our population per capita. Many of the European countries dealing with more severe outbreaks are ahead of us on the vaccine front, but that won’t save us from losing out on doses if Germany, Italy or Spain complain about exports to Canada.

We are a G7 country, we are a top 10 economy and we are in worse shape than many developing countries on the vaccine front. Canada should be a leader in both developing and manufacturing vaccines. The Brits started with nothing a year ago and now lead the world — we chose not to and our population is suffering.

That’s on Trudeau and Anand and it’s another reason I wouldn’t want her job today.

blilley@postmedia.com

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending